Vaccination has proven to be the most successful form of disease prevention available today. According to the World Health Organization, up to 3 million human lives are saved each year due to vaccination. However, infectious diseases still account for large numbers of the yearly reported casualties, especially in developing countries. Ever-relevant global outbreaks such as the current COVID-19 pandemic, necessitate a rapid response from scientists and companies worldwide, driving the development of new vaccine modalities and innovative technologies to combat diseases.
Over the last few decades, vaccine production has advanced and evolved significantly, and new vaccine modalities are on the rise. The increasing diversity of novel vaccines requires development of purification solutions tailored towards each unique molecule type, while minimizing time and resource consuming activities.
Join this webinar and learn more on novel purification technologies that can help accelerate early vaccine candidate screening and improve and streamline downstream processes of different vaccine modalities such as mRNA, recombinant proteins and Virus Like Particles (VLPs). In addition, a new scavenging method for the removal of Baculovirus process impurities will be presented.